New research advances link between taking low doses of Aspirin and preventing pre-eclampsia
New research has found that pregnant women who are at risk of pre-eclampsia could more than halve their chance of a premature birth by taking a low dose of aspirin.
Professor Kypros Nicolaides, a maternal foetal medicine specialist at King’s College London and the leading author of the research said: “This extensive study is definitive proof that women can take simple measures in the first trimester of pregnancy to significantly reduce their chances of developing pre-term pre-eclampsia.”
Aspirin is currently recommended in UK guidelines for women at risk of pre-eclampsia but the existing method only identified 40% of those at risk. This latest research advances the standard screening by using a new form of ultrasound screening which assesses the blood flow between mothers and babies. Nicolaides said: “by adding ultrasound measures and simple blood tests, we identified over 90% of cases of severe pre-eclampsia.”
Aspirin works by preventing the condition from occurring in the first place rather than by treating or curing the condition and should be taken throughout a pregnancy. The new findings also suggest that a higher dose of aspirin should be taken starting from earlier on in a pregnancy than the guidelines currently state.
*Please consult with your GP before undertaking any course of treatment